Emerging Role of MiR-192-5p in Human Diseases

被引:53
|
作者
Ren, Fu-jia [1 ]
Yao, Yao [2 ]
Cai, Xiao-yu [3 ]
Fang, Guo-ying [1 ]
机构
[1] Hangzhou Matern & Child Hlth Care Hosp, Hangzhou Womens Hosp, Dept Pharm, Hangzhou, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Dept Pharm, Sch Med, Hangzhou, Peoples R China
[3] Hangzhou First Peoples Hosp, Dept Pharm, Hangzhou, Peoples R China
关键词
miR-192-5p; human diseases; Cancers; respiratory system; digestive system; FATTY LIVER-DISEASE; MICRORNA EXPRESSION; CELL-PROLIFERATION; CANCER CELLS; HEPATOCELLULAR-CARCINOMA; CIRCULATING MICRORNAS; INFLAMMATORY RESPONSE; CISPLATIN RESISTANCE; UTERINE RECEPTIVITY; NONCODING RNAS;
D O I
10.3389/fphar.2021.614068
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
MicroRNAs (miRNAs) are a type of small non-coding RNAs that play an essential role in numerous biological processes by regulating the post-transcriptional expression of target genes. Recent studies have demonstrated that miR-192-5p, a member of the miR-192 family, partakes in several human diseases, especially various cancers, including cancers of the lung, liver, and breast. Importantly, the levels of miR-192-5p are abundant in biofluids, including the serum and urine, and the exosomal levels of miR-192-5p in circulation can aid in the diagnosis and prognosis of various diseases, such as chronic hepatitis B (CHB) infection disease. Notably, recent studies suggest that miR-192-5p is regulated by long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs). However, there are no comprehensive overviews on the role of miR-192-5p in human diseases. This review discusses the significant studies on the role of miR-192-5p in various human diseases, with special emphasis on the diseases of the respiratory and digestive systems.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] MiR-192-5p in the Kidney Protects Against the Development of Hypertension
    Baker, Maria Angeles
    Wang, Feng
    Liu, Yong
    Kriegel, Alison J.
    Geurts, Aron M.
    Usa, Kristie
    Xue, Hong
    Wang, Dandan
    Kong, Yiwei
    Liang, Mingyu
    HYPERTENSION, 2019, 73 (02) : 399 - 406
  • [2] Role of Mir-192-5p during Response to Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes
    Follo, Matilde Y.
    De Stefano, Alessia
    Mongiorgi, Sara
    Indio, Valentina
    Astolfi, Annalisa
    Ratti, Stefano
    Pellagatti, Andrea
    Fogli, Miriam
    Pession, Andrea
    Cavo, Michele
    Manzoli, Lucia
    Cocco, Lucio
    Boultwood, Jacqueline
    Parisi, Sarah
    Paolini, Stefania
    Finelli, Carlo
    BLOOD, 2021, 138 : 3673 - +
  • [3] mir-192-5p in the Kidney is Protective Against the Development of Hypertension
    Baker, Maria Angeles
    Liu, Pengyuan
    Liu, Yong
    Kriegel, Alison
    Regner, Kevin
    Liang, Mingyu
    HYPERTENSION, 2016, 68
  • [4] CANTHARIDIN INHIBITS COLON CANCER THROUGH MIR-192-5P UPREGULATION
    Xu, Zhenxing
    Yuan, Tingting
    Tong, Linlin
    Shao, Zhanyong
    Wang, Lianglong
    ACTA POLONIAE PHARMACEUTICA, 2024, 81 (04): : 619 - 627
  • [5] Serum miR-192-5p is a promising biomarker for lethal radiation injury
    Jia, Meng
    Wang, Zhanyu
    Liu, Xin
    Zhang, Hong
    Fan, Ying
    Cai, Dan
    Li, Yaqiong
    Shen, Liping
    Wang, Zhidong
    Wang, Qi
    Qi, Zhenhua
    TOXICOLOGY LETTERS, 2024, 399 : 43 - 51
  • [6] miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy
    Akpinar, Kadriye
    Aslan, Diler
    Fenkci, Semin Melahat
    Caner, Vildan
    DIAGNOSIS, 2022, 9 (04) : 499 - 507
  • [7] p53 activates miR-192-5p to mediate vancomycin induced AKI
    Chen, Jinwen
    Wang, Juan
    Li, Huiling
    Wang, Shixuan
    Xiang, Xudong
    Zhang, Dongshan
    SCIENTIFIC REPORTS, 2016, 6
  • [8] Downregulation of exosomal miR-192-5p and miR-204-5p in subjects with nonclassic apparent mineralocorticoid excess
    Alejandra Tapia-Castillo
    Dominic Guanzon
    Carlos Palma
    Andrew Lai
    Eric Barros
    Fidel Allende
    Andrea Vecchiola
    Carlos E. Fardella
    Carlos Salomón
    Cristian A. Carvajal
    Journal of Translational Medicine, 17
  • [9] p53 activates miR-192-5p to mediate vancomycin induced AKI
    Jinwen Chen
    Juan Wang
    Huiling Li
    Shixuan Wang
    Xudong Xiang
    Dongshan Zhang
    Scientific Reports, 6
  • [10] Serum miR-215-5p, miR-192-5p and miR-378a-5p as novel diagnostic biomarkers for periampullary adenocarcinoma
    Khan, Imteyaz Ahmad
    Singh, Nidhi
    Gunjan, Deepak
    Nayak, Baibaswata
    Dash, Nihar Ranjan
    Pal, Sujoy
    Lohani, Neelam
    Yadav, Rajni
    Gupta, Surabhi
    Saraya, Anoop
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 260